A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
This study has been withdrawn prior to enrollment.
(Sponsor decided not to go forward with the study.)
First Posted: June 10, 2008
Last Update Posted: August 21, 2009
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||June 2009 (Final data collection date for primary outcome measure)|